Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia

NCT00133991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: Filgrastim
BIOLOGICAL: Rituximab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Prednisone
DRUG: Hydrocortisone
DRUG: Vincristine
DRUG: Leucovorin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]